Guru Ownership Trend
Guru Analysis for Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $60.26 M.
Top institutional holders include Catherine Wood and Ken Fisher.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.62 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 993.9%. Conversely, Steven Cohen reduced exposure by 83.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Nurix Therapeutics, Inc. (NRIX)
Major holders include Catherine Wood ($43.5 M), Ken Fisher ($8.96 M), Cliff Asness ($4.35 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.42 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.62 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited NRIX. The total reported sell value was $11.32 M.
Yes, 0 managers opened new positions in NRIX, and 2 increased their existing holdings. The total reported buy value was $5.7 M.